-
ProKidney to Go Public Via Merger with Social Capital Suvretta Holdings Corp. III (DNAC)
-
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III

